JNT-517 is an orally active, selective SLC6A19 allosteric inhibitor with an IC 50 of 47 nM for human SLC6A19 . JNT-517 can be used for the study of phenylketonuria (PKU).
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Amino acid Transporter
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.